TET
Fiscal year ends September Quarters are offset from the calendar — Q1 is Oct–Dec

No description written yet.

Industry Specialty Chemicals Homepage treatt.com
Sector Basic Materials IR page treatt.com/investor-relations
Tags
—
Press page —

Metrics

Valuation  
Market cap —
Market cap (USD) —
P/E —
PEG —
P/BV —
P/S —
P/OCF —
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 3.7%
ROI 3.8%
ROIC 5.5%
Profit margin 3.8%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding No
Buying back stock —
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) —
Quality score -30.0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue 132.474M 153.066M 147.397M 140.185M 124.326M
Net profit 5.064M 14.401M 10.942M 13.315M 15.148M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Share price 4.28 4.28 6.91 3.61 9.36
Price performance 12m 0 -0.38 0.92 -0.61 —

Filed figures

Figure Sep 2020 Sep 2021 Sep 2022 Sep 2023 Sep 2024 Sep 2025
Balance sheet detail
Trade receivables (GBP) — 26.4M 37.1M 33M 37.1M 26.3M
↳ YoY growth +40.7% -11.2% +12.5% -29.1%
Borrowings, current (GBP) — 8.31M 18.2M 10.6M 2.13M 6.72M
Lease liabilities (GBP) — 1.05M 396,000 549,000 391,000 926,000
Cash and deposits (GBP) 5.25M 247,000 -3.82M 809,000 1.79M 1.75M
Intangible assets (GBP) — 2.42M 3.21M 2.75M 2.53M 2.23M
Right-of-use assets (GBP) — 1.56M 375,000 538,000 379,000 884,000
Net debt (borrowings + leases - cash) (GBP) — 9.11M 22.4M 10.4M 739,000 5.9M
Cash flow detail
Operating cash flow (GBP) — 8.57M -1.39M 21.5M 21.1M 11.3M
Purchases of property, plant and equipment (GBP) — -13.2M -11.8M -5.51M -5.43M -4.73M
Purchases of intangible assets (GBP) — -1.18M -925,000 -207,000 -243,000 -245,000
Change in receivables (cash effect) (GBP) — -2.68M -8.5M 3M -5.65M 5.96M
Change in inventories (cash effect) (GBP) — -11.9M -14.4M 2.51M 7.23M 7.71M
Change in payables (cash effect) (GBP) — 4.48M 4.36M -2.05M -939,000 2.39M
Dividends paid (cash effect) (GBP) — -3.7M -4.83M -4.8M -4.92M -5.15M
Interest paid (cash effect) (GBP) — -282,000 -390,000 -1.08M -992,000 -632,000
Income taxes paid (cash effect) (GBP) — -4.87M 443,000 -2.17M -3.73M 3.24M
Share-based compensation (GBP) — 1.73M 1.04M 1.22M 512,000 292,000
Operating cash flow before change in receivables (GBP) — 11.2M 7.12M 18.5M 26.7M 5.34M
Free cash flow (OCF - PPE - intangibles) (GBP) — -5.81M -14.2M 15.8M 15.4M 6.32M
Income detail
Total comprehensive income (GBP) — 15.8M 31.1M 6.33M 9.11M 3.43M
Reported Jan 4, 2023 Jan 4, 2023 Jan 4, 2023 Dec 12, 2023 Dec 19, 2024 Feb 4, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

News

08/09/2026

hero image all drinks

Today’s consumers want low/no drinks that deliver complexity, balance and a genuine sense of occasion. Discover how Treatt can help brands take their next concept far beyond the traditional mocktail.

Consumers are drinking differently

Some consumers are moderating their alcohol intake, some are seeking better-for-you choices, and others simply want greater flexibility. Whatever the motivation, choosing less alcohol does not mean accepting less from the experience.

That creates an exciting challenge for beverage developers. How do you build a drink that feels grown-up, rewarding and worthy of a social occasion, without relying on alcohol to provide body, warmth and complexity?

Creating an experience of its own

Successful premium low/no beverages need an identity of their own. Bright citrus might create the opening impression, followed by fruit or floral character, botanical depth, controlled sweetness and a lingering touch of spice. Texture and mouthfeel help bring the elements together, giving the finished beverage weight and presence.

This creates opportunities far beyond the traditional mocktail. Sparkling teas, botanical sodas, premium mixers, adult soft drinks, aperitif-inspired serves and wellness-forward beverages can all draw on the cues of established drinking occasions while offering something distinctive in their own right.

The building blocks of an adult taste experience

Sophistication is not about adding more ingredients; it comes from choosing complementary elements and balancing them well.

Citrus provides lift. Lemon, lime and more distinctive citrus profiles such as calamansi can bring freshness, brightness and definition.

Botanicals add depth. Juniper, chamomile and hibiscus can introduce floral, aromatic and more layered dimensions associated with adult drinking occasions.

Spice creates a finish. Chili, ginger and black pepper can deliver warmth, bite and a lingering sensation, helping create a more complete and engaging taste experience.

Tea brings structure. Authentic black tea character can provide structure, depth and familiarity, making it a versatile foundation for sparkling or fruit-led concepts.

Fruit adds character and approachability. Tropical profiles such as mango and pineapple can bring brightness, juiciness and body while creating space for more adventurous pairings.

Sweetness and mouthfeel create balance. Used carefully, they can round sharper notes, support body and help the beverage feel complete without allowing sweetness to dominate.


mocktail pack  assets 12

Five routes to sophistication

Treatt’s new “Beyond the Mocktail” demo pack shows how familiar cocktail cues can be reinterpreted across five distinctive low/no concepts. Each brings together carefully selected ingredients to create depth, balance and a memorable finish.

Spicy Honey Mockarita:
A margarita-inspired serve combining bright TreattClear™ Zesty Lime with the rich sweetness of Honey Treattarome Dark 9801 . Natural Chilli Fusion adds warming depth, creating a bold, zesty mocktail with balanced sweetness, heat and a lingering premium finish.
**
Mango Chamomile Mock Collins:**
Chamomile Concentrate and Mango Treattarome Ripe 9831 create a soft floral and tropical base. Juniper Fusion adds botanical complexity, while Natural Chilli Fusion provides subtle warmth rather than overt heat.
**
Pineapple Juniper Mock Fizz:**
Natural Pineapple Fusion delivers tropical brightness, while Juniper Fusion brings aromatic botanical complexity to this tonic-based concept. TreattClear™ Black Pepper adds a sophisticated bite, while Brix Booster 9888 supports sweetness, balance and body.

Hibiscus Calamansi Cos-No-Politan:
Hibiscus Concentrate and Calamansi Treattarome create a vibrant combination of floral and citrus notes, enhanced by cranberry and lime. Sugar Treattarome 9806 supports rounded sweetness and mouthfeel, producing a refreshing, contemporary mocktail with strong visual appeal.

Pineapple Ginger Spritz Tea:
TrueTaste™ Black Tea and Black Tea Treattarome Iced provide an authentic tea foundation, lifted by TreattClear™ Zesty Lemon and Natural Pineapple Fusion. Ginger Fusion Hot and Ginger Treattarome add warming spice, while Brix Booster 9888 supports balance and mouthfeel.

Inspiration from every drinking occasion

The next opportunity may not begin with a mocktail at all. White wine, rosé, red wine, beer, cider, sparkling wine and aperitif occasions can each provide sensory inspiration for product development.

White wine and rosé-inspired concepts may call for freshness, fruit character and carefully balanced sweetness. Beer and cider applications may call for authenticity, body and a satisfying finish, while aperitif and spirit-inspired drinks can draw on botanicals, spice and controlled bitterness.

Different occasions demand different sensory cues, but the same principles apply: balance, complexity, texture, freshness and premium taste. The aim is to understand what makes an adult drinking occasion satisfying, then use those principles to build a compelling experience with its own distinctive identity.

Build your next adult beverage with Treatt

As low/no drinking continues to evolve, the brands that stand out will be those that treat flavor as the starting point, not a compromise. Consumers may be drinking differently, but their expectations for taste, quality and enjoyment are only becoming higher.

Treatt can help you explore ingredient solutions across mocktails, sparkling teas, premium mixers, botanical beverages and other adult beverage formats. From citrus lift and botanical depth to authentic tea, warming spice, fruit character, sweetness and mouthfeel, our teams can help you turn an initial idea into a balanced, differentiated beverage.

Ready to go beyond the mocktail? Request the demo pack and discover what’s possible.

Share


Related

The Evolution of Fragrance: Discover Treatt at  SIMPPAR 2026

[The Evolution of Fragrance: Discover Treatt at SIMPPAR 2026 \

01/05/2026](https://www.treatt.com/news/the-evolution-of-fragrance-discover-treatt-at-simppar-2026 "View - The Evolution of Fragrance: Discover Treatt at SIMPPAR 2026")

SIMPPAR is the oldest and most important European exhibition dedicated exclusively to the raw materials for…

Trend-Driven, Taste-Led: Redefining Indulgence at the CSA Roundtable

[Trend-Driven, Taste-Led: Redefining Indulgence at the CSA Roundtable \

16/04/2026](https://www.treatt.com/news/trend-driven-taste-led-redefining-indulgence-at-the-csa-roundtable "View - Trend-Driven, Taste-Led: Redefining Indulgence at the CSA Roundtable")

On May 7th, Treatt is heading to the CSA (Chemical Sources Association) Roundtable in Newark, New Jersey. The…

Seven Key Trends Emerging from Natural Products Expo West 2026

[Seven Key Trends Emerging from Natural Products Expo West 2026 \

25/03/2026](https://www.treatt.com/news/seven-key-trends-emerging-from-natural-products-expo-west-2026 "View - Seven Key Trends Emerging from Natural Products Expo West 2026")

A few weeks ago, the Treatt team headed to Anaheim for Natural Products Expo West 2026. With thousands of…

Back to top

 Sign up for updates Contact us

sustainability

We understand that everything we do has an impact on people and the planet, which is why we operate in an ethical and socially responsible way. With a deep-rooted respect for the world’s resources, we are committed to reducing our environmental impact whilst ensuring a sustainable, fair and rewarding future for all our employees, suppliers and growers – wherever they live.


Terms of Use Privacy Policy Cookies Statement T & C (Sales) T & C (Purchase) Slavery & Human Trafficking Statement Supplier Code of Conduct GRI Standards Index Statement of Investment Principles Implementation Statement Gender Pay Gap


TREATT and Treatt Droplet logo are Registered Trade Marks of Treatt Limited
Copyright © 2026

Website by KISS

×

Important disclaimer

Access to this area of the website may be restricted under securities laws or regulations in certain jurisdictions. This notice requires you to confirm certain matters (including that you are not resident in such a jurisdiction), before you may obtain access to the information on this area of the website. These materials are not directed at or to be accessed by persons resident in any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of that jurisdiction or would result in a requirement of Treatt to comply with any consent or other formality which Treatt regards as unduly onerous.

Recommended offer for Treatt PLC (Treatt) by Döhler Finance Management B.V. (Döhler) (the Offer)

Access to the website

You are attempting to enter the part of the website that is designated for the publication of documents and information in connection with the Offer.

If you would like to view this part of the website, please read this notice carefully. This notice applies to all persons who view this part of the website and, depending on where you are located, may affect your rights or responsibilities. Treatt reserves the right to amend or update this notice at any time and you should, therefore, read it in full each time you visit the site. In addition, the contents of this part of the website may be amended at any time, in whole or in part, at the sole discretion of Treatt.

This part of the website contains electronic versions of materials relating to the Offer. The materials you are seeking to access are made available by Treatt in good faith and for information purposes only and are subject to the terms and conditions set out below. Any person seeking to access this part of the website represents and warrants to Treatt that they are doing so for information purposes only.

To allow you to view information about the Offer, you must read this notice and then click "AGREE". If you are unable to agree, you should click "DISAGREE" and you will not be able to view information about the Offer.

Nothing on this part of the website, nor anything which can be downloaded from it, constitutes an offer for sale or subscription or any solicitation for any offer to purchase or subscribe for any securities (or solicitation of any votes attaching to securities which are the subject of the Offer) in any jurisdiction in which such offer or solicitation is unlawful.

The Offer will be made solely by means of a scheme document or offer document which will contain the full terms and conditions of the Offer, including details on how it may be accepted. Any decision made in relation to the Offer should be made solely on the basis of the information provided in any such document.

Overseas jurisdictions

Viewing the materials you are seeking to access may be restricted under securities laws in certain jurisdictions. All persons resident outside of the United Kingdom who wish to view this part of the website must first satisfy themselves that they are not subject to any local requirements which prohibit or restrict them from doing so and should inform themselves about, and observe, any applicable legal or regulatory requirements applicable in their jurisdiction.

These materials are not directed at or accessible by persons resident in any jurisdiction if to do so would constitute a violation of the relevant laws or regulations of that jurisdiction.

You should not download, mail, forward, distribute, send or share the information or documents contained on this part of the website to any person. In particular, you should not mail, forward, distribute or send the information or documents contained therein to any jurisdiction where it would be unlawful to do so. It is your responsibility to satisfy yourself as to the full observance of any laws and regulatory requirements. If you are not permitted to view the information in this website, or viewing the information would result in a breach of the above, or you are in any doubt as to whether you are permitted to view the information, please exit this website. Treatt and its advisers do not assume any responsibility for any violation by any person of these restrictions.

This part of the website contains information that has been prepared for the purposes of complying with English law and the UK Takeover Code and the information disclosed may not be the same as that which would have been disclosed if this information had been prepared in accordance with the laws and regulations of any jurisdiction outside England.

Notice to U.S. Investors

The Offer relates to an offer for the shares of a UK company and is being made by means of a scheme of arrangement provided for under English company law. The Offer, to be implemented by way of a scheme of arrangement, is not subject to the tender offer rules or the proxy solicitation rules under the U.S. Securities Exchange Act of 1934, as amended (the U.S. Exchange Act). Accordingly, the Offer is subject to the disclosure and procedural requirements and practices applicable to a scheme of arrangement involving a target company in the UK admitted to trading on the Main Market of the London Stock Exchange, which differ from the disclosure and procedural requirements of the U.S. tender offer and proxy solicitation rules.

The financial information with respect to Treatt included in the following materials has been or will have been prepared in accordance with International Financial Reporting Standards (IFRS) and thus may not be comparable to the financial information of U.S. companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the U.S.

If in the future, Döhler exercises its right to implement the Offer by way of a takeover offer and determines to extend the takeover offer into the U.S., the Offer will be made in compliance with applicable U.S. laws and regulations, including to the extent applicable Section 14(e) of the U.S. Exchange Act and Regulation 14E thereunder. Such a takeover offer would be made in the U.S. by Döhler and no one else.

In the event that the Offer is implemented by way of a takeover offer, in accordance with normal United Kingdom practice and pursuant to Rule 14e-5 (b) under the U.S. Exchange Act, Döhler or its nominees, or its brokers (acting as agents), may from time to time make certain purchases of or arrangements to purchase, shares or other securities of Treatt outside of the U.S., other than pursuant to the takeover offer, until the date on which the takeover offer becomes effective, lapses or is otherwise withdrawn. These purchases may occur either in the open market at prevailing prices or in private transactions at negotiated prices and would comply with applicable law, including the U.S. Exchange Act. Any information about such purchases shall be disclosed as required in the UK, will be reported to a Regulatory Information Service of the London Stock Exchange and will be available on the London Stock Exchange website at www.londonstockexchange.com.

The receipt of cash pursuant to the scheme by U.S. Shareholders (defined as shareholders who are U.S. persons as defined in the U.S. Internal Revenue Code) as consideration for the transfer of Treatt shares pursuant to the scheme may be a taxable transaction for U.S. federal income tax purposes and under applicable U.S. state and local, as well as foreign and other, tax laws. Each Treatt shareholder (including U.S. shareholders) is urged to consult his independent professional adviser immediately regarding the tax consequences of the transaction applicable to him.

Neither the SEC nor any U.S. state securities commission has approved, disapproved or passed judgment upon the fairness of the Offer or passed upon the adequacy or accuracy of the materials included herein. Any representation to the contrary is a criminal offence in the U.S.

Some or all of Treatt's and Döhler's respective officers and directors reside outside the U.S., and some or all of their respective assets are or may be located in jurisdictions outside the U.S. Therefore, investors may have difficulty effecting service of process within the U.S. upon those persons or recovering against Treatt or Döhler or their respective officers or directors on judgments of U.S. courts, including judgments based upon the civil liability provisions of the U.S. federal securities laws. Further, it may be difficult to compel a non-U.S. company and its affiliates to subject themselves to a U.S. court's judgment. It may not be possible to sue Treatt, Döhler or their respective officers or directors in a non-U.S. court for violations of the U.S. securities laws.

Cautionary Note Regarding Forward-Looking Statements

The materials on this part of the website, including information included or incorporated by reference, may contain certain forward-looking statements with respect to the financial condition, results of operations and business of Döhler and/or Treatt. These statements are based on the current expectation of the management of Döhler and/or Treatt and are naturally subject to uncertainty and changes in circumstances. These forward-looking statements may be identified by words such as "will", "may", "should", "could", "would", "can", "believes", "intends", "expects", "indicates", "anticipates" or similar words or terms or by discussions of, inter alia, strategies, goals or plans. Forward-looking statements include statements relating to the following: (i) future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; (ii) business and management strategies and the expansion and growth of Döhler's or Treatt's operations and potential synergies resulting from the Offer; and (iii) the effects of government regulation on Döhler's or Treatt's business.

By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that may or may not occur in the future. There are several factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are changes in the global, political, economic, business, competitive, market and regulatory forces, future exchange and interest rates, changes in tax rates and future business combinations or dispositions. Due to such uncertainties, Treatt cannot give any assurance that any forward-looking statement will prove to be correct in the future. Treatt does not undertake any obligation to update or publicly revise forward-looking statements (whether as a result of new information, future events or otherwise), except to the extent required by applicable law or regulation. You are therefore cautioned not to place undue reliance on these forward-looking statements. Unless expressly stated otherwise, no statement contained or referred to in this website is intended to be a profit forecast or profit estimate for any period and no statement should be interpreted to mean that earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the relevant party to the Offer.

Responsibility

In relation to any Offer-related materials accessible on this area of the website please note any statement of responsibility contained therein.

The documents included in this part of the website issued or published by Treatt speak only at the specified date of the relevant document and Treatt has, and accepts, no responsibility or duty to update or revise such documents.

In relation to any such announcements or other Offer-related materials issued or published by Döhler, or which relate to Döhler and its group, that are accessible on this website, the only responsibility accepted by Treatt and its directors is for the correctness and fairness of its reproduction.

Neither the directors of Treatt, nor Döhler nor any of their respective affiliated companies, have reviewed, and no such person is or shall be responsible for or accepts any liability in respect of, any information contained on any other website which may be linked to or from this part of the website.

If you are in any doubt about the contents of this part of the website or the action you should take, you should seek your own financial advice from an independent financial adviser authorised under the Financial Services and Markets Act 2000 or, if you are located outside the United Kingdom, from an appropriately authorised independent financial adviser.

Confirmation of understanding and acceptance

  • I have read and understood the notice set out above and I agree to be bound by its terms.
  • I am not (nor do I act on behalf of someone who is) resident in any country that renders the accessing of the materials on this website or parts of it illegal.
  • I will not print, download, or otherwise seek to copy, mail, forward, distribute or send any of the materials on this part of the website to any other person at any time.
  • I represent and warrant to Treatt that I intend to access this part of the website for information purposes only.

If you are not able to give these confirmations, you should click on DISAGREE below.

AGREE DISAGREE

Disclosure Table Bull 0 Bear 0 Routine

| OFFEREE: Advanced Medical Solutions Group plc | LEI: 213800HJP6OWOSZI1L74 |

| Offer period commenced: 12:00 21-May-2026 |

| 5p ordinary | ISIN: GB0004536594 | NSI: 220,712,799 |

| OFFEROR: H.B. Fuller Medical Adhesive Technologies Inc (a wholly-owned subsidiary of H.B. Fuller Company) | LEI: |

| Offeror identified: 12:00 21-May-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Alternative Income REIT plc | LEI: 213800MPBIJS12Q88F71 |

| Offer period commenced: 15:54 15-May-2026 |

| 1p ordinary | ISIN: GB00BDVK7088 | NSI: 80,500,000 |

| OFFEROR: Glenstone REIT plc | LEI: |

| Offeror identified: 15:54 15-May-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Animalcare Group plc | LEI: 213800A7XPQ528RMCC72 |

| Offer period commenced: 07:00 16-Apr-2026 |

| 20p ordinary | ISIN: GB0032350695 | NSI: 69,045,945 |

| OFFEROR: CCP Paw 2 Limited (a wholly-owned indirect subsidiary of funds managed or advised by Charterhouse Capital Partners LLP) | LEI: |

| Offeror identified: 07:00 16-Apr-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Aptitude Software Group plc | LEI: 2138009VHA1WI2VKMA28 |

| Offer period commenced: 07:00 08-Apr-2026 |

| 7 1/3p ordinary | ISIN: GB00BJV2F804 | NSI: 54,521,064 |

| OFFEROR: No named offeror |

| | | |

| OFFEREE: Beazley plc | LEI: 213800VTOMUWD41GIT12 |

| Offer period commenced: 12:55 19-Jan-2026 |

| 5p ordinary | ISIN: GB00BYQ0JC66 | NSI: 601,533,666 |

| OFFEROR: Zurich Insurance Group Ltd | LEI: |

| Offeror identified: 12:55 19-Jan-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Bluefield Solar Income Fund Limited | LEI: 2138004ATNLYEQKY4B30 |

| Offer period commenced: 07:00 05-Nov-2025 |

| 0.01p ordinary | ISIN: GG00BB0RDB98 | NSI: 592,080,033 |

| OFFEROR: Drax Smart Generation Holdco Limited (a wholly-owned subsidiary of Drax Group plc) | LEI: |

| Offeror identified: 07:00 01-Jun-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: CAB Payments Holdings plc | LEI: 8945007OZHZDN4LW1G21 |

| Offer period commenced: 07:00 02-Feb-2026 |

| 0.033 1/3p ordinary | ISIN: GB00BMCYKB41 | NSI: 254,143,218 |

| OFFEROR: Mara BidCo Ltd. (a newly formed company indirectly owned or controlled by Helios Investors V, L.P. and Helios Investors V (Mauritius) L.P. and Helios Fairfax Partners Corporation) | LEI: |

| Offeror identified: 07:00 02-Feb-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Capricorn Energy plc | LEI: 213800ZJEUQ8ZOC9AL24 |

| Offer period commenced: 16:23 11-Mar-2026 |

| 799 / 122p ordinary | ISIN: GB00BNKT5L33 | NSI: 70,558,339 |

| OFFEROR: Alamadiyaf al-Masiyyah for Trading LLC (a member of the Cafani Group) | LEI: |

| Offeror identified: 16:23 11-Mar-2026 |

| Rule 2.6 deadline: to be determined |

| Disclosure of dealings and positions in this offeror is not required |

| OFFEROR: Genel Energy No.9 Limited (a company indirectly owned by Genel Energy plc) | LEI: |

| Offeror identified: 07:00 02-Jul-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Checkit plc | LEI: 213800556WJOWQNT2R68 |

| Offer period commenced: 07:00 26-Mar-2026 |

| 5p ordinary | ISIN: GB00B0C5RG72 | NSI: 108,008,562 |

| OFFEROR: No named offeror |

| | | |

| OFFEREE: Cordel Group plc | LEI: 213800ZUBMOCVHSSJC14 |

| Offer period commenced: 16:00 13-May-2026 |

| 1p ordinary | ISIN: GB00BYZQM590 | NSI: 216,923,230 |

| OFFEROR: Vossloh Digital Solutions GmbH (a wholly-owned subsidiary of Vossloh AG) | LEI: |

| Offeror identified: 16:00 13-May-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: CyanConnode Holdings plc | LEI: 213800MDLW3GKKW5TT58 |

| Offer period commenced: 13:30 03-Feb-2026 |

| 2p ordinary | ISIN: GB00BF93WP34 | NSI: 359,035,103 |

| OFFEROR: Esyasoft Holding Ltd | LEI: |

| Offeror identified: 13:30 03-Feb-2026 |

| Rule 2.6 deadline: 17:00 21-Jul-2026 |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Deltic Energy plc | LEI: 213800TS8K1D27AFP275 |

| Offer period commenced: 16:10 22-Apr-2026 |

| 10p ordinary | ISIN: GB00BNTY2N01 | NSI: 93,096,600 |

| OFFEROR: NEO NEXT+ Energy Upstream UK Limited | LEI: |

| Offeror identified: 11:30 07-May-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: easyJet plc | LEI: 2138001S47XKWIB7TH90 |

| Offer period commenced: 19:03 29-May-2026 |

| 27 2/7p ordinary | ISIN: GB00B7KR2P84 | NSI: 758,010,025 |

| ADR | ISIN: US2778562098 | |

| OFFEROR: Castlelake, L.P. in partnership with Peter Bellew and Mark Breen as EU national individual investors | LEI: |

| Offeror identified: 19:03 29-May-2026 |

| Rule 2.6 deadline: 17:00 05-Jul-2026 |

| Disclosure of dealings and positions in this offeror is not required |

| OFFEREE: Frenkel Topping Group plc | LEI: 213800I5L3K7AT7A4R20 |

| Offer period commenced: 11:00 02-Jun-2025 |

| 0.5p ordinary | ISIN: GB00B01YXQ71 | NSI: 128,013,064 |

| OFFEROR: Irwell Financial Services Bidco Limited (a newly formed company indirectly owned by a limited partnership managed by Harwood Private Equity LLP) | LEI: |

| Offeror identified: 11:00 02-Jun-2025 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Gamma Communications plc | LEI: 213800LAQZXPRIZUEH50 |

| Offer period commenced: 18:02 07-Apr-2026 |

| 0.25p ordinary | ISIN: GB00BQS10J50 | NSI: 89,795,374 |

| OFFEROR: Epiris LLP | LEI: |

| Offeror identified: 07:15 13-May-2026 |

| Rule 2.6 deadline: 17:00 08-Jul-2026 |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Integrated Diagnostics Holdings plc | LEI: 2138007JN9NUWKKTS790 |

| Offer period commenced: 10:15 23-Jun-2026 |

| USD 0.25 ordinary | ISIN: JE00BLKGSR75 | NSI: 581,326,272 |

| OFFEROR: Hena Holdings Ltd (a company wholly owned by Dr Hend El Sherbini and Dr Moamena Abdul Wahab Kamel) | LEI: |

| Offeror identified: 10:15 23-Jun-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: International Personal Finance plc | LEI: 213800II1O44IRKUZB59 |

| Offer period commenced: 07:01 30-Jul-2025 |

| 10p ordinary | ISIN: GB00B1YKG049 | NSI: 222,608,258 |

| OFFEROR: IPF Parent Holdings Limited (a newly formed company in the same group as BasePoint Capital LLC) | LEI: |

| Offeror identified: 07:01 30-Jul-2025 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Intertek Group plc | LEI: 2138003GAT25WW1RN369 |

| Offer period commenced: 11:31 16-Apr-2026 |

| 1p ordinary | ISIN: GB0031638363 | NSI: 153,931,794 |

| OFFEROR: Isotope Bidco Limited (a newly formed company to be indirectly owned by EQT X EUR SCSp and EQT X USD SCSp, each acting through its manager EQT Fund Management S.a.r.l., together with certain indirect minority shareholders including, among others, Luxinva and Mubadala) | LEI: |

| Offeror identified: 11:37 16-Apr-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Intuitive Investments Group plc | LEI: 2138004A32UIY92WWR66 |

| Offer period commenced: 07:00 08-Apr-2026 |

| 10p ordinary | ISIN: GB00BPTH6Y20 | NSI: 240,059,774 |

| OFFEROR: Acceler8 Ventures plc | LEI: 2138004B1HKZP1OR2C72 |

| Offeror identified: 07:00 08-Apr-2026 |

| Rule 2.6 deadline: N/A |

| 1p ordinary | ISIN: JE00BNG2DL20 | NSI: 750,000 |

| OFFEREE: IP Group plc | LEI: 213800HG22UM138WFG43 |

| Offer period commenced: 16:06 22-Jun-2026 |

| 2p ordinary | ISIN: GB00B128J450 | NSI: 883,427,642 |

| OFFEROR: Railways Pension Trustee Company Limited | LEI: |

| Offeror identified: 16:06 22-Jun-2026 |

| Rule 2.6 deadline: 17:00 20-Jul-2026 |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: JTC plc | LEI: 213800DVUG4KLF2ASK33 |

| Offer period commenced: 11:39 29-Aug-2025 |

| 1p ordinary | ISIN: JE00BF4X3P53 | NSI: 174,639,924 |

| OFFEROR: Papilio Bidco Limited (a newly incorporated company indirectly wholly-owned by funds advised by Permira Advisers LLP) | LEI: |

| Offeror identified: 11:39 29-Aug-2025 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Kore Potash plc | LEI: 213800NWX7EHG4UVC107 |

| Offer period commenced: 07:30 04-Nov-2025 |

| USD 0.001 ordinary | ISIN: GB00BYP2QJ94 | NSI: 5,175,938,315 |

| CDI | ISIN: AU000000KP25 | |

| OFFEROR: No named offeror |

| OFFEREE: Mind Gym plc | LEI: 213800ER1PA5QSNKIL80 |

| Offer period commenced: 18:17 27-Jan-2026 |

| 0.001p ordinary | ISIN: GB00BF3SQB83 | NSI: 100,338,882 |

| OFFEROR: No named offeror |

| | | |

| OFFEREE: Pharos Energy plc | LEI: 549300DDKLXYLLO4N524 |

| Offer period commenced: 07:00 24-Jun-2026 |

| 5p ordinary | ISIN: GB00B572ZV91 | NSI: 416,320,478 |

| OFFEROR: Ratio Petroleum Energy LP | LEI: |

| Offeror identified: 07:00 24-Jun-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Picton Property Income Limited | LEI: 213800RYE59K9CKR4497 |

| Offer period commenced: 07:00 13-Jan-2026 |

| Ordinary NPV | ISIN: GB00B0LCW208 | NSI: 513,827,021 |

| OFFEROR: A consortium comprising LondonMetric Property plc and Schroder Real Estate Investment Trust Limited | LEI: 213800OCERWWPQDURL87 549300ZIJJTMTIIQJP67 |

| Offeror identified: 10:05 11-Feb-2026 |

| Rule 2.6 deadline: N/A |

| LondonMetric Property plc 10p ordinary | ISIN: GB00B4WFW713 | NSI: 2,344,782,058 |

| Schroder Real Estate Investment Trust Limited ordinary NPV | ISIN: GB00B01HM147 | NSI: 489,110,576 |

| OFFEREE: PPHE Hotel Group Limited | LEI: 2138003H1BZGR6KM5823 |

| Offer period commenced: 07:00 14-Nov-2025 |

| Ordinary NPV | ISIN: GG00B1Z5FH87 | NSI: 41,858,631 |

| OFFEROR: No named offeror |

| | | |

| OFFEREE: Ramsdens Holdings plc | LEI: 2138004439PRUV6WB123 |

| Offer period commenced: 07:00 23-Jun-2026 |

| 1p ordinary | ISIN: GB00BDR6V192 | NSI: 32,664,782 |

| OFFEROR: Chess Bidco Limited (an indirect wholly-owned subsidiary of FirstCash Holdings, Inc.) | LEI: |

| Offeror identified: 07:00 23-Jun-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Schroders plc | LEI: 2138001YYBULX5SZ2H24 |

| Offer period commenced: 07:00 12-Feb-2026 |

| 20p ordinary | ISIN: GB00BP9LHF23 | NSI: 1,610,711,278 |

| OFFEROR: Pantheon, LLC (a newly incorporated subsidiary of Nuveen, LLC, a Teachers Insurance and Annuity Association of America company) | LEI: |

| Offeror identified: 07:00 12-Feb-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: SEGRO plc | LEI: 213800XC35KGM9NFC641 |

| Offer period commenced: 07:00 24-Jun-2026 |

| 10p ordinary | ISIN: GB00B5ZN1N88 | NSI: 1,354,073,367 |

| OFFEROR: Prologis, Inc. | LEI: 529900DFH19P073LZ636 |

| Offeror identified: 07:00 24-Jun-2026 |

| Rule 2.6 deadline: 17:00 22-Jul-2026 |

| USD 0.01 common | ISIN: US74340W1036 | NSI: 932,983,874 |

| OFFEREE: Senior plc | LEI: 5493002HQHWN5JQHKQ51 |

| Offer period commenced: 07:00 27-Feb-2026 |

| 10p ordinary | ISIN: GB0007958233 | NSI: 419,418,082 |

| OFFEROR: Zeus UK Bidco Limited (a newly formed company to be indirectly controlled by investment funds advised by affiliates of Tinicum Incorporated and Blackstone Inc.) | LEI: |

| Offeror identified: 10:00 03-Mar-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Spire Healthcare Group plc | LEI: 213800IBJPW3SE2RA350 |

| Offer period commenced: 19:36 18-Sep-2025 |

| 1p ordinary | ISIN: GB00BNLPYF73 | NSI: 402,759,599 |

| OFFEROR: Funds advised by Toscafund Asset Management LLP | LEI: |

| Offeror identified: 07:00 14-May-2026 |

| Rule 2.6 deadline: 17:00 09-Jul-2026 |

| Disclosure of dealings and positions in this offeror is not required |

| | | |

| OFFEREE: Tate & Lyle plc | LEI: 2138008K14474WPKZ244 |

| Offer period commenced: 13:07 14-May-2026 |

| 29 1/6p ordinary | ISIN: GB00BP92CJ43 | NSI: 445,450,004 |

| ADR | ISIN: US8765707067 | |

| OFFEROR: Ingredion Incorporated | LEI: |

| Offeror identified: 13:07 14-May-2026 |

| Rule 2.6 deadline: N/A |

| Disclosure of dealings and positions in this offeror is not required |

| OFFEREE: Union Jack Oil plc | LEI: 2138005VW7IUUUPY5Q88 |

| Offer period commenced: 07:00 15-Jun-2026 |

| 5p ordinary | ISIN: GB00BLH1S316 | NSI: 146,565,896 |

| OFFEROR: Reabold Resources plc | LEI: 2138006DR8T8XE87OC49 |

| Offeror identified: 07:00 15-Jun-2026 |

| Rule 2.6 deadline: N/A |

| 100p ordinary | ISIN: GB00BVK55Z16 | NSI: 14,501,215 |

| OFFEREE: Zinnwald Lithium plc | LEI: 213800LXW3HPZ7ZSBE37 |

| Offer period commenced: 17:12 14-May-2026 |

| 1p ordinary | ISIN: GB00BFN4GY99 | NSI: 542,354,605 |

| OFFEROR: AMG Lithium B.V. (a direct wholly-owned subsidiary of AMG Critical Materials N.V.) | LEI: 5493006MN6OH67U2YI74 |

| Offeror identified: 17:12 14-May-2026 |

| Rule 2.6 deadline: N/A |

| EUR 0.02 ordinary | ISIN: NL0000888691 | NSI: 35,598,141 |

| Notes: |

| 1. | Rule 8 of the Takeover Code (the "Code") sets out the circumstances in which Dealing Disclosures and/or Opening Position Disclosures are required to be made by the parties to an offer, persons acting in concert with them, persons with an interest in relevant securities of 1% or more and exempt principal traders ("EPTs") connected with the parties to an offer. |

| 2. | Where an offeror is marked "Disclosure of dealings and positions in this offeror is not required", dealings and positions in relevant securities of that offeror are not required to be disclosed under Rule 8. This is either because it has been announced that the offer or possible offer is, or is likely to be, solely in cash or because disclosure is not required for some other reason. |

| 3. | Dealings and positions required to be disclosed under Rule 8 of the Code include dealings and positions in derivatives referenced to, and options in respect of, relevant securities of an offeree company and, where appropriate, an offeror (see Note 2 above). |

| 4. | The information set out in the Disclosure Table relating to the relevant securities in issue of an offeree company or of an offeror (and any amendments thereto) has been extracted from the relevant announcement made by such company under Rule 2.9 of the Code. Similarly, details of any deadline set under Rule 2.6 by which a potential offeror must announce either a firm intention to make a bid or that it does not intend to make an offer (or, in the case of Rule 2.6(a), by which the Panel must consent to an extension of the deadline) has been extracted from the relevant announcement made by the offeree company. |

| 5. | Additions and deletions of offeree companies and offerors are reflected in the Disclosure Table throughout the day, following the relevant announcement. Other amendments may also be made throughout the day. In any event, details of the classes of relevant securities issued by an offeree or offeror company, the number of such securities in issue ("NSI") and the International Securities Identification Number ("ISIN") of such securities announced under Rule 2.9 of the Code before 5.00 pm each day will be included in the final version of the Disclosure Table by 5.30 pm that day. The final version of the Disclosure Table issued each day will be marked "Final" and persons required to make Dealing Disclosures and Opening Position Disclosures are advised to use that final version. Any changes to the Rule 2.6 deadline of a potential offeror will also be reflected in the "Final" version of the Disclosure Table, although any such changes will not be shown in the "Amendments" section at the top of the Disclosure Table. |

| 6. | Dealing Disclosures by the parties to an offer, persons acting in concert with them and connected EPTs must be made by no later than 12 noon on the business day (as defined in the Code) following the date of the relevant dealing and Dealing Disclosures by persons with an interest in relevant securities of 1% or more must be made by 3.30 pm on the business day following the date of the relevant dealing. |

| 7. | Opening Position Disclosures by the parties to an offer and by connected EPTs must be made by no later than 12 noon on the 10th business day after the commencement of the offer period or the announcement that first identifies an offeror (as the case may be). Where required, Opening Position Disclosures by persons with interests in relevant securities of 1% or more must be made by no later than 3.30 pm on the 10th business day after the commencement of the offer period or the announcement that first identifies an offeror (as the case may be). Details of the time and date at which an offer period commenced and at which an offeror was first identified are set out in the Disclosure Table. In order to calculate the deadline for Opening Position Disclosures, it is therefore necessary to count forward 10 business days from the relevant date. |

| 8. | Opening Position Disclosures and Dealing Disclosures required under Rule 8 of the Code must be made to a Regulatory Information Service ("RIS"). |

| 9. | This Note is applicable if it says "See Note 9 below" by the name of the company in the Disclosure Table above. The Executive has granted the company a dispensation from the requirements under the Code that announcements must be published via a RIS. The company is instead required to publish all announcements on its website. The Executive has also granted a dispensation from Note 3 on Rule 8 of the Code that disclosures made under Rule 8 of the Code must be made to a RIS. Therefore, Opening Position Disclosures and Dealing Disclosures required under Rule 8 of the Code may be made to the company at the address stated in the announcement that commenced the offer period. |

| 10. | The following are approved Regulatory Information Services: | |

| . | Business Wire Regulatory Disclosure provided by Business Wire | +44 (0)20 7626 1982 |

| . | EQS IR COCKPIT provided by EquityStory AG | +49 89 21 02 98-50 |

| . | GlobeNewswire provided by West Digital Media Solutions | +44 (0)20 3753 2071 |

| . | MFN provided by Modular Finance | +44 (0)20 3026 4414 |

| . | PR Newswire Disclose provided by PR Newswire | +44 (0)20 7454 5210 |

| . | RNS provided by the London Stock Exchange | +44 (0)20 7797 4400 |

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TABRTMFTMTJMMAF

London Stock Exchange Notice Bull 0 Bear 0 Routine

03 July 2026

NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE

03/07/2026 - 08:00

At the request of the company the following securities have been cancelled from admission to trading on London Stock Exchange with effect from the time and date of this notice.

| TREATT PLC |

| 213800G4OJM9F7G9LG39 |

| ORDINARY SHARES OF 2P EACH, FULLY PAID | (BKS7YK0)(GB00BKS7YK08) | TREATT/PAR VTG FPD 0.02 |

If you have any queries relating to the above content, please contact us on +44 (0) 20 7797 4310.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

SENAKBBPNBKDBOK

Prompts

Treatt plc (ticker TET), listed in United Kingdom.

Company History

Date Change Detail
Apr 29, 2026 Delisted Left the market: no longer admitted to a UK venue (FCA FIRDS); reason not on disk. Its figures and people stay on this page.

ETFs Holding Treatt plc

ETF Weight in ETF Shares Market value As of
KNOW 0.37% 6,410 $ 25.89K Jun 30, 2026